FIBRALIGN CORP has a total of 21 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets medical technology, pharmaceuticals and macromolecular chemistry and polymers are PHILLIPS VICTOR MATTHEW, 3-D MATRIX LTD and LACERTA TECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | China | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Macromolecular chemistry and polymers | |
#4 | Biotechnology | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Paukshto Michael V | 12 |
#2 | Martin George R | 8 |
#3 | Zaitseva Tatiana | 7 |
#4 | Zaitseva Tatiana S | 7 |
#5 | Paukshto Mikhail Vitoldovich | 7 |
#6 | Mcmurtry David Harwood | 7 |
#7 | Mcmurtry David H | 4 |
#8 | Bobrov Yuri Alexandrovich | 4 |
#9 | Hadamitzky Catarina | 2 |
#10 | Huang Ngan F | 2 |
Publication | Filing date | Title |
---|---|---|
US2019015549A1 | Biocomposites And Methods Of Making The Same | |
CN107849512A | Composition for therapy of the targeted delivery based on nucleic acid | |
US2016256605A1 | Method And Device For Lymphedema Treatment | |
US2015202408A1 | Medical device and delivery method onto offset surface of mammal tissue | |
US2013287744A1 | Biocomposites and methods of making the same | |
US2014242347A1 | Graft for directed vascular and lymphatic regeneration and methods to guide endothelial cell assembly | |
WO2012034110A2 | Biodegradable multilayer constructs | |
AU2009282095A1 | Biocomposites and methods of making the same | |
EP2148887A2 | Oriented collagen-based materials, films and methods of making same | |
US2008115724A1 | Liquid film applicator assembly and rectilinear shearing system incorporating the same |